ot: US drug company knew that 'Prozac could lead to violence' - Congressman Maurice Hinchey needs thimerosal information

[Guest guest]

Congressman Maurice Hinchey is another person who can be contacted about

the CDC's 1999 findings about thimerosal's adverse effects and about the

CDC's deliberate diluting of their own data so as to mask the findings (1).

http://www.house.gov/hinchey/

http://www.house.gov/hinchey/contact/

Washington Office:

Office of Rep. Hinchey

2431 Rayburn H.O.B.

Washington, DC 20515

Phone: (202) 225-6335

Fax: (202) 226-0774

From Mark Blaxill of SafeMinds.org:

CDC thimerosal findings in 1999 - subsequent data dilution - Generation

Zero analysis is up on Safe Minds web-site

text synopsis

http://www.safeminds.org/Generation%20Zero%20Syn.pdf

full analysis, with charts

http://www.safeminds.org/Generation%20Zero%20Pres.pdf

* * *

US drug company knew that 'Prozac could lead to violence'

RHIANNON EDWARD

http://news.scotsman.com/health.cfm?id=1477962004

CONFIDENTIAL drug company documents appearing to suggest a link between

a popular anti-depressant and suicide and violence have been handed to

authorities in the United States, it emerged today.

The British Medical Journal (BMJ) received the documents concerning the

drug fluoxetine (Prozac) from an anonymous source and has now turned

them over to the US Food and Drug Administration (FDA).

The papers reportedly went missing during a lawsuit filed on behalf of

victims of a workplace shooting carried out by ph Wesbecker in

Louisville, Kentucky, in 1989.

Wesbecker, who had a long history of depression and had been put on

Prozac a month before the shootings, killed eight people and injured 12

others before killing himself.

In 1994, some of the relatives of the victims brought a civil suit

against Eli Lilly, the makers of Prozac, alleging the company had for

years known about the side-effects - including the fact Prozac might

increase violence.

Although the company won the case, it was later forced to admit it had

made a secret settlement with the plaintiffs, making the verdict invalid.

The documents sent to the BMJ include reviews and memos indicating that

Eli Lilly officials were aware in the 1980s that Prozac had troubling

side-effects and sought to minimise their likely negative effect on

prescribing, according to Jeanne Lenzer, writing in the journal. One of

the documents, dated November 1988, reported that in clinical trials,

Prozac could cause behavioural disturbances.

The FDA has recently issued a warning that anti-depressants can cause

stimulatory side-effects such as agitation, panic attacks and

aggressiveness.

Dr Kapit, the administration's clinical reviewer who approved

Prozac, told the BMJ that he was not given the Lilly data. " These data

are very important. If this report was done by Lilly or for Lilly, it

was their responsibility to report it to us and to publish it, " he said.

The administration has agreed to review the documents passed on by the BMJ.

The documents are now being reviewed by the office of Congressman

Maurice Hinchey to determine whether Lilly withheld data.

" This is an alarming study, " Mr Hinchey said. " This case demonstrates

the need for Congress to mandate the complete disclosure of all clinical

studies for FDA-approved drugs so patients and their doctors, not drug

companies, decide if the benefits of taking a certain medicine outweigh

the risks. "

In a statement to the BMJ, Lilly said: " Prozac has helped to

significantly improve millions of lives. It is one of the most studied

drugs in the history of medicine, and has been prescribed for more than

50 million people worldwide.

" The safety and efficacy of Prozac is well studied, well documented and

well established. "

*

The material in this post is distributed without profit to those

who have expressed a prior interest in receiving the included

information for research and educational purposes.

For more information go to:

http://www4.law.cornell.edu/uscode/17/107.html

<http://oregon.uoregon.edu/%7Ecsundt/documents.htm>

http://oregon.uoregon.edu/~csundt/documents.htm

<http://oregon.uoregon.edu/%7Ecsundt/documents.htm>

If you wish to use copyrighted material from this email for

purposes that go beyond 'fair use', you must obtain permission

from the copyright owner.